This website is for informational and educational purposes only. Please do not self-medicate; contact a medical professional for advice before administration. This website is for informational and educational purposes only. Please do not self-medicate; contact a medical professional for advice before administration.

Aminoglutethimide

PubChem CID: 2145

Connections displayed (default: 10).
Loading graph...

Compound Synonyms aminoglutethimide, 125-84-8, dl-Aminoglutethimide, Cytadren, Orimeten, p-Aminoglutethimide, Elipten, 3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione, Aminoglutetimida, 2,6-Piperidinedione, 3-(4-aminophenyl)-3-ethyl-, 3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione, Aminoglutethimidum, 2-(p-Aminophenyl)-2-ethylglutarimide, Ba-16038, Aminoglutetimide, 3-Ethyl-3-(p-aminophenyl)-2,6-dioxopiperidine, Ba 16038, CCRIS 7562, Aminoglutethimidum [INN-Latin], Aminoglutetimida [INN-Spanish], C 16038-BA, NSC-330915, Glutethimide, para-amino, Glutarimide, 2-(p-aminophenyl)-2-ethyl-, EINECS 204-756-4, MFCD00010122, 3-(4-Aminophenyl)-3-ethyl-2,6-piperidindion, UNII-0O54ZQ14I9, BRN 0210656, AG-1, CHEBI:2654, 3-(4-aminophenyl)-3-ethyl-piperidine-2,6-dione, DTXSID8022589, HSDB 7494, 0O54ZQ14I9, alpha-(p-Aminophenyl)-alpha-ethylglutarimide, CHEMBL488, DTXCID202589, Aminoglutethimide [USP:INN:BAN], NSC330915, NSC 330915, NSC 755868, (+/-)-p-AMINOGLUTETHIMIDE, .alpha.-(p-Aminophenyl)-.alpha.-ethylglutarimide, (RS)-2-(4-Amino-phenyl)-2-ethyl-glutarimide, (RS)-3-(4-Amino-phenyl)-3-ethyl-2,6-dioxo-piperidine, Aminoglutethimidum (INN-Latin), Aminoglutetimida (INN-Spanish), AMINOGLUTETHIMIDE (MART.), AMINOGLUTETHIMIDE [MART.], Aminoglutethimide (USP:INN:BAN), AMINOGLUTETHIMIDE (EP IMPURITY), AMINOGLUTETHIMIDE [EP IMPURITY], AMINOGLUTETHIMIDE (EP MONOGRAPH), AMINOGLUTETHIMIDE (USP IMPURITY), AMINOGLUTETHIMIDE [EP MONOGRAPH], AMINOGLUTETHIMIDE [USP IMPURITY], Cytadren (TN), SMR000326785, aminoglutethimide (AG), SR-01000075596, Aminoblastin, Mamomit, Orimenten, Orimetene, Rodazol, Aminoglutethimide (USP/INN), Aminoglutethimid, 3-(p-Aminophenyl)-3-ethylpiperidine-2,6-dione, NCGC00016379-01, CAS-125-84-8, Prestwick_243, Spectrum_000040, (y)-p-Aminoglutethimide, Aminoglutethimide AG, 4, (?)-p-Aminoglutethimide, Prestwick0_000244, Prestwick1_000244, Prestwick2_000244, Prestwick3_000244, Spectrum2_000093, Spectrum3_000296, Spectrum4_000144, Spectrum5_000802, A 9657, SCHEMBL4306, Aminoglutethimide (Cytadren), Lopac0_000124, BSPBio_000028, BSPBio_001832, KBioGR_000588, KBioSS_000400, (A+/-)-p-Aminoglutethimide, MLS000859924, MLS001213216, AMINOGLUTETHIMIDE [MI], DivK1c_000884, SPECTRUM1500115, SPBio_000046, SPBio_002247, AMINOGLUTETHIMIDE [INN], BDBM9460, BPBio1_000032, GTPL7054, AMINOGLUTETHIMIDE [HSDB], AMINOGLUTETHIMIDE [VANDF], HMS502M06, KBio1_000884, KBio2_000400, KBio2_002968, KBio2_005536, KBio3_001332, NINDS_000884, AMINOGLUTETHIMIDE [WHO-DD], HMS1568B10, HMS1920C09, HMS2090I05, HMS2091I09, HMS2095B10, HMS2231M19, HMS3259H10, HMS3260I10, HMS3372M07, HMS3655O17, HMS3712B10, Pharmakon1600-01500115, BCP28501, HY-B0237, 2, 3-(4-aminophenyl)-3-ethyl-, Tox21_110406, Tox21_303497, Tox21_500124, BBL010961, CCG-38911, MFCD03094024, MFCD03094025, NSC755868, STK802074, Aminoglutethimide - Bio-X trade mark, AKOS004120070, AKOS022060651, Tox21_110406_1, AMINOGLUTETHIMIDE [ORANGE BOOK], DB00357, FA17754, LP00124, NC00714, NSC-755868, PB48252, SDCCGSBI-0050112.P005, IDI1_000884, SMP1_000017, NCGC00015110-02, NCGC00015110-03, NCGC00015110-04, NCGC00015110-05, NCGC00015110-06, NCGC00015110-07, NCGC00015110-09, NCGC00015110-12, NCGC00015110-21, NCGC00093615-01, NCGC00093615-02, NCGC00093615-03, NCGC00093615-04, NCGC00093615-05, NCGC00257263-01, NCGC00260809-01, AC-12456, AS-13282, BA164155, NCI60_002900, SY294287, SY344150, SBI-0050112.P004, DB-021640, DB-072002, DB-072275, A1947, AB00051935, alpha-(4-Aminophenyl)-alpha-ethylglutarimide, EU-0100124, NS00010649, S1672, SW196550-3, ( inverted question mark)-p-Aminoglutethimide, EN300-53368, VU0243029-3, C07617, D00574, D88489, AB00051935-09, AB00051935-11, AB00051935_12, AB00051935_13, Q241150, SR-01000075596-1, SR-01000075596-4, SR-01000075596-6, (R)-3-(4-Aminophenyl)-3-ethylpiperidine-2,6-dione, (S)-3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione, BRD-A25234499-001-05-0, BRD-A25234499-001-09-2, BRD-A25234499-001-17-5, BRD-A25234499-001-18-3, BRD-A25234499-001-19-1, Z800191876, Aminoglutethimide, European Pharmacopoeia (EP) Reference Standard, Aminoglutethimide, United States Pharmacopeia (USP) Reference Standard, 204-756-4
Topological Polar Surface Area 72.2
Hydrogen Bond Donor Count 2.0
Heavy Atom Count 17.0
Isotope Atom Count 0.0
Molecular Complexity 321.0
Database Name cmaup_ingredients;npass_chem_all;pubchem
Defined Atom Stereocenter Count 0.0
Uniprot Id P00189, P11511, P05093, n.a., P30099, P22443, P24557, P05108, Q01453, P08684, Q13526, O89049, O75496, P11308, O75874, Q9Y6L6, Q9NPD5, P27695, O95342, Q92887, O15438, O15439, P19838
Iupac Name 3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione
Prediction Hob 1.0
Target Id NPT441, NPT3159, NPT300, NPT6540, NPT796, NPT109
Xlogp 1.2
Molecular Formula C13H16N2O2
Prediction Swissadme 1.0
Inchi Key ROBVIMPUHSLWNV-UHFFFAOYSA-N
Fcsp3 0.3846153846153846
Logs -1.833
Rotatable Bond Count 2.0
Logd 0.861
Compound Name Aminoglutethimide
Prediction Hob Swissadme 1.0
Exact Mass 232.121
Formal Charge 0.0
Monoisotopic Mass 232.121
Hydrogen Bond Acceptor Count 3.0
Molecular Weight 232.28
Covalent Unit Count 1.0
Total Atom Stereocenter Count 1.0
Total Bond Stereocenter Count 0.0
Esol -2.2787310705882353
Inchi InChI=1S/C13H16N2O2/c1-2-13(8-7-11(16)15-12(13)17)9-3-5-10(14)6-4-9/h3-6H,2,7-8,14H2,1H3,(H,15,16,17)
Smiles CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N
Nring 2.0
Defined Bond Stereocenter Count 0.0